ArticleInfectious medicine2022

Tocilizumab in severe COVID-19 - A randomized, double-blind, placebo-controlled trial.

Muhammad Irfan Malik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.